BRIP1 - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 605882
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509

Panel

DNA-first hereditary breast cancer

Turnaround time
Urgent (2-3 weeks)
Performing laboratory
Radboudumc & Maastricht UMC+
€ 0

DNA-first hereditary breast cancer



€ 0

DNA-first hereditary breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Urgent (2-3 weeks)

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • CNV analysis of all genes based on NGS

Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood




€ 0
Panel

panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)

Turnaround time
3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 750

panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)



€ 750

panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • CNV analysis of all genes based on NGS
  • Exome analysis (WES or WGS data)

Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 750
Gene

ATM - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

ATM - risk factor breast cancer



€ 509

ATM - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • Comprehensive preconception carrier test panel¹
  • Hereditary cancer panel
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • Movement disorders panel
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • Primary immunodeficiencies panel

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 607585
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

BARD1 - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

BARD1 - risk factor breast cancer



€ 509

BARD1 - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 601593
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 320

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)



€ 320

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • Comprehensive preconception carrier test panel¹
  • Hereditary cancer panel
  • Inherited bone marrow failure and/or predisposition panel to hematological malignancies
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries
Remarks
Analysis of a known familial mutation only (screening).

OMIM: 113705
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 320
Gene

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 320

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)



€ 320

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • Comprehensive preconception carrier test panel¹
  • Hereditary cancer panel
  • Inherited bone marrow failure and/or predisposition panel to hematological malignancies
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • Sonic hedgehog medulloblastoma panel

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)
Remarks
Analysis of a known familial mutation only (screening).
MLPA analysis only upon request.

OMIM: 600185
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 320
Gene

BRIP1 - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

BRIP1 - hereditary ovarian cancer (only familial mutation testing)



€ 509
Gene

CHEK2 - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

CHEK2 - risk factor breast cancer



€ 509

CHEK2 - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • Hereditary cancer panel
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 604373
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

PALB2 - hereditary breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

PALB2 - hereditary breast cancer



€ 509

PALB2 - hereditary breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • Hereditary cancer panel
  • Inherited bone marrow failure and/or predisposition panel to hematological malignancies
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • Skin disorders panel¹
  • Sonic hedgehog medulloblastoma panel

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 610355
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

RAD51C - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

RAD51C - hereditary ovarian cancer (only familial mutation testing)



€ 509

RAD51C - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)
Remarks
MLPA analysis only upon request.

OMIM: 613399
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

RAD51D - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

RAD51D - hereditary ovarian cancer (only familial mutation testing)



€ 509

RAD51D - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)
Remarks
MLPA analysis only upon request.

OMIM: 614291
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509